Trials / Completed
CompletedNCT05279573
Efficacy of a Dietary Ingredient Combination With Omega-3 for Joint Function
Randomized Controlled Intervention Study to Analyze the Efficacy of a Dietary Ingredient Combination With Omega-3 for Joint Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Universidad Católica San Antonio de Murcia · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Randomized, controlled, double-blind intervention study of four parallel branches depending on the product consumed, to analyze the efficacy of an Omega-3 based product on the mobility and functionality of the evaluated joint.
Detailed description
The duration of the study will be 60 days (8 weeks). Each day they will have to consume the product under investigation. Subjects who meet the selection criteria will be randomized into each of the study groups (A, B, C o D, depending on the group in which they have been randomized). Each day the subjects will have to fill in a diary regarding pain and concomitant medication. They will make a total of two visits to the research laboratory and will perform the tests pre-established in the protocol. In addition, a follow-up telephone call will be made after 30 days of consume. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain the results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 and/or botanical ingredient | Consumption for 60 days. Subjects should consume two capsules in the morning and two capsules in the afternoon. |
| OTHER | Control product consumption | Product with identical characteristics to the experimental product. Consumption for 60 days. Subjects should consume two capsules in the morning and two capsules in the afternoon. |
Timeline
- Start date
- 2022-02-14
- Primary completion
- 2022-11-29
- Completion
- 2022-12-23
- First posted
- 2022-03-15
- Last updated
- 2022-12-28
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05279573. Inclusion in this directory is not an endorsement.